Novumed's profile picture. We are an independent strategy consulting & advisory firm for the life sciences industry; one of the few global, specialized advisors with clear industry focus.

Novumed Life Science

@Novumed

We are an independent strategy consulting & advisory firm for the life sciences industry; one of the few global, specialized advisors with clear industry focus.

Often, only 15% of prescribers control 50% of pharma sales. Do you know your A,B,C prescribers? Full article at novumed.com


Novumed advises private equity investor Paragon Partners on its planned acquisition of the operating business of medical supplier Balda AG


Novumed advises Equistone Private Equity (Barclays Capital) on sale of CU Uetikon Chemie to Novacap (Commercial Vendor Due Diligence)


Of a total of 3234 scanners in 1098 private German radiology practices 386 are older than 7years. Full database at novumed.com


172 of 2057 German hospitals currently renovating, 44% of all operating rooms in only 2 states. Hospital database at novumed.com


Of the current 138 molecules in the cancer market, tyrosine kinase inhibitors will out-grow even monocl. AB. Study at novumed.com


Novumed celebrates its 10 year anniversary and continues to strengthen its leading position in consulting & advisory services in healthcare


Why is a new biological prescribed twice as much by physicians of a certain sales region - Publication on effective selling coming soon


Meet us at CPHI Frankfurt (Germany) in October


Meet our management team on a road show in New York and New Jersey between the 20th and 24th of May


Visit our presentation of the global healthcare logistics market at the Coolchain Logistics conference in Basel on the 29th-30th of January


Meet us at the MEDTEC Europe in Stuttgart from the 26th until the 28th of February


When the financial markets collapsed, global licensing deals reached an all time high. Our licensing publication has more: novumed. com


Meet our advisory and consulting experts at the BioEurope in Hamburg and the MEDICA in Duesseldorf


Medical technology helped many industry groups to survive the financial crisis? Read the full publication now at novumed.com.


Is medical technology a safe haven to volatile industries? More details in a new publication soon at novumed.com.


7% of the European population is suffering from orphan diseases. More details in a new publication soon at novumed.com.


There are 7000 orphan diseases which benefit from marketing exclusivity for 7 to 10 years. Publication with more details soon at novumed.com


Hypertension, Hypercholesterolemia and Diabetes were the 3 top selling therapeutic areas in 2010. Full article at ww.novumed.com


Meet the Novumed team through the new image movie (4 min) at www.novumed.com


Loading...

Something went wrong.


Something went wrong.